Overview

Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Safety, tolerability, pharmacokinetics (PK), cardiac conduction and food effect study on single and multiple ascending doses of KAR5585 in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Karos Pharmaceuticals